Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
SNOASonoma Pharmaceuticals, Inc.
Filed Feb 14, 2014 · 10-Q · 45 days after period end · 0001019687-14-000553
| Metric | Q3 2014 | Q3 2010 |
|---|---|---|
| Revenue | $3.29M | $2.31M |
| Net Income | -$611.00K | -$2.23M |
| EPS Diluted | -$0.09 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 14, 2014 · 45 d after period end
